24/7 Wall St. ran a screen of the Wall Street firms we cover looking for biotech stocks trading under $10 that had big upside potential for 2014. These are potentially the next great growth…
The Cowen biotechnology team has a list of top 10 surprises that are specific to the very hot biotechnology sector.
ThinkstockPfizer Inc.’s (NYSE: PFE) patent protecting popular erectile dysfunction drug Viagra from generic competition may not expire until April 2020, but Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) has acquired rights to launch its generic version…
ThinkstockThe Obama administration appointed former Microsoft Corp. (NASDAQ: MSFT) executive Kurt DelBene as senior advisor to Kathleen Sebelius, Secretary of Health and Human Services. She is the person most blamed for the broken Healthcare.gov website. Whatever…
ThinkstockThe United States is far from being the healthiest country in the world. The country struggles with obesity and heart disease, and life expectancy is worse than in countries such as Slovenia and Chile.…
ThinkstockCredit Suisse is out and pounding the table that biotechnology cannot be ignored in 2014. Biotech has been the top-performing sector for the past three years, with year-to-date performance up 73%. Given those kinds…
ThinkstockGilead Sciences Inc. (NASDAQ: GILD) has been on fire, so much that two insiders decided to stuff their holiday stockings with about $23 million in stock sales. Chairman and CEO John Martin sold 282,242…
ThinkstockTeva Pharmaceutical Industries Ltd. (NYSE: TEVA) has moved from a great growth story to one of promise, to one of habitual disappointment. The company’s 2014 guidance is soft yet again. The company also is…
OncoMed Pharmaceuticals just went from being an obscure biotech to one on the map with more security than it had. The company can thank Celgene for this development.
ThinkstockResearcher find two measurements which best gauge air quality. One comes from object data about the quality itself. The second comes from the perceptions of the people who live in the nations. Each rates stands distinguishable…
ThinkstockSpeculation has run hot that Swiss drugmaker Novartis A.G. (NYSE: NVS) would announced further restructuring at its investor day in London. Instead, on Friday the company announced a $5 billion share buyback program and…
ThinkstockInvestors have enjoyed a handy recovery in the turnaround of Boston Scientific Corp. (NYSE: BSX). Perhaps that should even say “finally enjoyed” in the turnaround. After all, this stock has been in turnaround mode…
ThinkstockAny time investors look for companies growing sales the most, one area that almost always stands out is the up and coming biotech stocks. After all, sales can grow from close to nothing into…
ThinkstockHealth care has been a top sector for investors this year. The research team at Oppenheimer continues to believe that health care remains well positioned to deliver further market-topping returns in 2014. Earnings revisions…
ThinkstockHorizon Pharma Inc. (NASDAQ: HZNP) is having a stellar day after breaking news that it entered into a pact with AstraZeneca PLC (NYSE: AZN) for the U.S. rights to VIMOVO. The move aims to…